Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.
作者信息
Kalogeropoulos Andreas P, Georgiopoulou Vasiliki V, Borlaug Barry A, Gheorghiade Mihai, Butler Javed
机构信息
Division of Cardiology, Emory University, Atlanta, GA, USA.
出版信息
Circ Heart Fail. 2013 May;6(3):584-93. doi: 10.1161/CIRCHEARTFAILURE.112.000096.
Abstract
摘要
相似文献
1
Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.左心室功能不全合并肺动脉高压：第2部分：预后、无创评估、治疗及未来研究
Circ Heart Fail. 2013 May;6(3):584-93. doi: 10.1161/CIRCHEARTFAILURE.112.000096.
2
Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.大剂量米力农对重度左心室功能不全患者血流动力学变量及肺血管阻力的影响：一项肺动脉高压可逆性的快速检测
J Am Coll Cardiol. 1996 Dec;28(7):1775-80. doi: 10.1016/S0735-1097(96)00399-3.
3
Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension.左心室辅助装置作为治疗伴有肺动脉高压的充血性心力衰竭患者心脏移植的过渡手段
ASAIO J. 2005 Jul-Aug;51(4):456-60. doi: 10.1097/01.mat.0000169125.21268.d7.
4
Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.舒张期肺动脉梯度作为左心室辅助装置植入后右心衰竭的预测因子。
J Am Heart Assoc. 2019 Aug 20;8(16):e012073. doi: 10.1161/JAHA.119.012073. Epub 2019 Aug 14.
5
Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease.左心疾病所致肺动脉高压患者中负舒张压肺压力梯度的决定因素及其预后意义。
Eur J Heart Fail. 2017 Jan;19(1):88-97. doi: 10.1002/ejhf.675. Epub 2016 Oct 17.
6
Acute left ventricular failure after bilateral lung transplantation for idiopathic pulmonary arterial hypertension.特发性肺动脉高压双侧肺移植术后急性左心室衰竭
J Thorac Cardiovasc Surg. 2013 Jan;145(1):e7-9. doi: 10.1016/j.jtcvs.2012.10.020. Epub 2012 Nov 8.
7
Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy.毛细血管前肺动脉高压和右心室扩张可预测心脏再同步治疗的临床结局。
JACC Heart Fail. 2014 Jun;2(3):230-7. doi: 10.1016/j.jchf.2014.02.004. Epub 2014 Apr 30.
8
Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.肺血管有效动脉弹性作为右心室后负荷的指标及其在左心疾病所致肺动脉高压中的预后价值。
Circ Heart Fail. 2018 Apr;11(4):e004436. doi: 10.1161/CIRCHEARTFAILURE.117.004436.
9
Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.右心室对急性肺血管扩张的反应可预测晚期心力衰竭和肺动脉高压患者的预后。
Am Heart J. 2003 Feb;145(2):310-6. doi: 10.1067/mhj.2003.146.
10
Sildenafil in heart transplant candidates with pulmonary hypertension.患有肺动脉高压的心脏移植候选者使用西地那非的情况。
Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):375-84. doi: 10.1016/j.acvd.2015.01.013. Epub 2015 Apr 25.
引用本文的文献
1
Can Right Heart Catheterization Improve the Prediction of Positive Response to Resynchronization Therapy?右心导管检查能否改善对心脏再同步治疗阳性反应的预测？
Biomedicines. 2025 Feb 14;13(2):467. doi: 10.3390/biomedicines13020467.
2
Ventricular Function and Cardio-Ankle Vascular Index in Patients With Pulmonary Artery Hypertension.肺动脉高压患者的心室功能和心踝血管指数。
Vasc Health Risk Manag. 2022 Dec 28;18:889-904. doi: 10.2147/VHRM.S385536. eCollection 2022.
3
Improvement of Left Ventricular Ejection Fraction and Pulmonary Hypertension Are Significant Prognostic Factors in Heart Failure with Reduced Ejection Fraction Patients.左心室射血分数的改善和肺动脉高压是射血分数降低的心力衰竭患者的重要预后因素。
J Cardiovasc Imaging. 2019 Oct;27(4):257-265. doi: 10.4250/jcvi.2019.27.e36.
4
Use of Cardiac Imaging to Evaluate Cardiac Function and Pulmonary Hemodynamics in Patients with Heart Failure.心力衰竭患者心脏功能和肺血流动力学的心脏成像评估。
Curr Cardiol Rep. 2019 May 10;21(6):53. doi: 10.1007/s11886-019-1138-4.
5
Hemodynamics of the diastolic pressure gradients in acute heart failure: implications for the diagnosis of pre-capillary pulmonary hypertension in left heart disease.急性心力衰竭中舒张压梯度的血流动力学：对左心疾病中毛细血管前性肺动脉高压诊断的意义。
Pulm Circ. 2019 Jan-Mar;9(1):2045894018815438. doi: 10.1177/2045894018815438. Epub 2018 Nov 13.
6
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭的临床表型
J Am Heart Assoc. 2016 Jan 25;5(1):e002477. doi: 10.1161/JAHA.115.002477.
7
Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.超声心动图评估肺动脉收缩压与心力衰竭患者门诊预后的相关性。
J Am Heart Assoc. 2014 Feb 3;3(1):e000363. doi: 10.1161/JAHA.113.000363.
本文引用的文献
1
Late-Breaking Clinical Trial Abstracts.最新临床试验摘要
Circulation. 2015 Dec 8;132(23):2267-85. doi: 10.1161/CIR.0000000000000334.
2
Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.慢性西地那非使用对心脏移植后肺血液动力学和临床结局的影响。
J Heart Lung Transplant. 2012 Dec;31(12):1281-7. doi: 10.1016/j.healun.2012.09.009. Epub 2012 Nov 3.
3
The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study.磷酸二酯酶 5 抑制对晚期心力衰竭和肺动脉高压患者血流动力学、功能状态和生存的影响：一项病例对照研究。
Int J Cardiol. 2013 Sep 20;168(1):60-5. doi: 10.1016/j.ijcard.2012.09.074. Epub 2012 Oct 8.
4
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design.磷酸二酯酶抑制剂 RasE-5 改善舒张性心力衰竭患者临床状况和运动能力（RELAX）试验：原理与设计。
Circ Heart Fail. 2012 Sep 1;5(5):653-9. doi: 10.1161/CIRCHEARTFAILURE.112.969071.
5
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation.世界卫生组织肺动脉高压专家组 2 类：成人左心疾病相关性肺动脉高压——国际心肺移植学会肺动脉高压理事会的总结声明。
J Heart Lung Transplant. 2012 Sep;31(9):913-33. doi: 10.1016/j.healun.2012.06.002.
6
Clinical adoption of prognostic biomarkers: the case for heart failure.临床采用预后生物标志物：心力衰竭案例。
Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):3-13. doi: 10.1016/j.pcad.2012.05.004.
7
Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.5型环磷酸鸟苷水解磷酸二酯酶的心脏作用：从实验模型到临床试验
Curr Heart Fail Rep. 2012 Sep;9(3):192-9. doi: 10.1007/s11897-012-0101-0.
8
Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design.与肺动脉高压相关的左心室收缩功能障碍利奥西呱试验（LEPHT）：原理和设计。
Eur J Heart Fail. 2012 Aug;14(8):946-53. doi: 10.1093/eurjhf/hfs071. Epub 2012 Jun 20.
9
Soluble guanylate cyclase: a potential therapeutic target for heart failure.可溶性鸟苷酸环化酶：心力衰竭的潜在治疗靶点。
Heart Fail Rev. 2013 Mar;18(2):123-34. doi: 10.1007/s10741-012-9323-1.
10
Pulmonary artery hypertension in heart transplant recipients: how much is too much?心脏移植受者肺动脉高压：多少算太多？
Eur J Cardiothorac Surg. 2012 Nov;42(5):864-9; discussion 869-70. doi: 10.1093/ejcts/ezs102. Epub 2012 Mar 7.
Zotero 插件